Goldman Sachs’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.2M | Buy |
1,433,508
+427,175
| +42% | +$6.24M | ﹤0.01% | 2377 |
|
|
2025
Q4 | $16.1M | Buy |
1,006,333
+164,306
| +20% | +$2.33M | ﹤0.01% | 2590 |
|
|
2025
Q3 | $9.3M | Buy |
842,027
+403,007
| +92% | +$4.4M | ﹤0.01% | 3034 |
|
|
2025
Q2 | $3.72M | Sell |
439,020
-1,192,462
| -73% | -$9.56M | ﹤0.01% | 3692 |
|
|
2025
Q1 | $13.1M | Sell |
1,631,482
-120,692
| -7% | -$978K | ﹤0.01% | 2437 |
|
|
2024
Q4 | $15.7M | Sell |
1,752,174
-655,847
| -27% | -$5.35M | ﹤0.01% | 2363 |
|
|
2024
Q3 | $17.7M | Buy |
2,408,021
+153,364
| +7% | +$951K | ﹤0.01% | 2180 |
|
|
2024
Q2 | $12.9M | Buy |
2,254,657
+102,503
| +5% | +$540K | ﹤0.01% | 2272 |
|
|
2024
Q1 | $10.8M | Buy |
2,152,154
+103,698
| +5% | +$703K | ﹤0.01% | 2397 |
|
|
2023
Q4 | $18.4M | Buy |
2,048,456
+576,120
| +39% | +$4.74M | ﹤0.01% | 1979 |
|
|
2023
Q3 | $11.4M | Sell |
1,472,336
-271,869
| -16% | -$2.66M | ﹤0.01% | 2278 |
|
|
2023
Q2 | $16.9M | Buy |
1,744,205
+754,631
| +76% | +$7.83M | ﹤0.01% | 1987 |
|
|
2023
Q1 | $10.8M | Buy |
989,574
+518,861
| +110% | +$4.57M | ﹤0.01% | 2345 |
|
|
2022
Q4 | $2.03M | Sell |
470,713
-3,527
| -0.7% | -$20.5K | ﹤0.01% | 3938 |
|
|
2022
Q3 | $3.57M | Sell |
474,240
-246,194
| -34% | -$2.13M | ﹤0.01% | 3447 |
|
|
2022
Q2 | $7.24M | Buy |
720,434
+410,727
| +133% | +$4.59M | ﹤0.01% | 2803 |
|
|
2022
Q1 | $3.83M | Buy |
309,707
+36,285
| +13% | +$561K | ﹤0.01% | 3610 |
|
|
2021
Q4 | $6.25M | Buy |
273,422
+97,377
| +55% | +$2.31M | ﹤0.01% | 3181 |
|
|
2021
Q3 | $3.9M | Buy |
176,045
+4,674
| +3% | +$74.2K | ﹤0.01% | 3577 |
|
|
2021
Q2 | $2.22M | Sell |
171,371
-128,331
| -43% | -$1.63M | ﹤0.01% | 4105 |
|
|
2021
Q1 | $3.89M | Buy |
299,702
+128,134
| +75% | +$1.86M | ﹤0.01% | 3371 |
|
|
2020
Q4 | $2.37M | Sell |
171,568
-8,207
| -5% | -$119K | ﹤0.01% | 3606 |
|
|
2020
Q3 | $2.65M | Sell |
179,775
-89,071
| -33% | -$1.29M | ﹤0.01% | 3366 |
|
|
2020
Q2 | $4.37M | Sell |
268,846
-341,436
| -56% | -$5.47M | ﹤0.01% | 2897 |
|
|
2020
Q1 | $8.86M | Sell |
610,282
-12,522
| -2% | -$221K | ﹤0.01% | 2172 |
|
|
2019
Q4 | $12.6M | Sell |
622,804
-1,030,898
| -62% | -$9.5M | ﹤0.01% | 2258 |
|
|
2019
Q3 | $8.83M | Buy |
1,653,702
+518,674
| +46% | +$3.14M | ﹤0.01% | 2414 |
|
|
2019
Q2 | $7.47M | Sell |
1,135,028
-244,273
| -18% | -$1.56M | ﹤0.01% | 2578 |
|
|
2019
Q1 | $8.96M | Sell |
1,379,301
-283,471
| -17% | -$1.88M | ﹤0.01% | 2509 |
|
|
2018
Q4 | $11.3M | Sell |
1,662,772
-80,568
| -5% | -$465K | ﹤0.01% | 2257 |
|
|
2018
Q3 | $11.6M | Sell |
1,743,340
-90,985
| -5% | -$510K | ﹤0.01% | 2339 |
|
|
2018
Q2 | $10.3M | Buy |
1,834,325
+592,330
| +48% | +$3.3M | ﹤0.01% | 2389 |
|
|
2018
Q1 | $6.45M | Buy |
1,241,995
+47,445
| +4% | +$254K | ﹤0.01% | 2703 |
|
|
2017
Q4 | $5.41M | Buy |
1,194,550
+319,639
| +37% | +$1.77M | ﹤0.01% | 2955 |
|
|
2017
Q3 | $5.49M | Sell |
874,911
-1,550
| -0.2% | -$9.77K | ﹤0.01% | 3058 |
|
|
2017
Q2 | $5.37M | Buy |
876,461
+529,816
| +153% | +$3.57M | ﹤0.01% | 2992 |
|
|
2017
Q1 | $2.54M | Sell |
346,645
-928,051
| -73% | -$4.29M | ﹤0.01% | 3509 |
|
|
2016
Q4 | $2.68M | Buy |
1,274,696
+899,387
| +240% | +$2.89M | ﹤0.01% | 3581 |
|
|
2016
Q3 | $1.13M | Buy |
+375,309
| New | +$1.01M | ﹤0.01% | 4297 |
|
|
2016
Q2 | – | Sell |
-21,118
| Closed | -$61K | – | 7012 |
|
|
2016
Q1 | $61K | Buy |
+21,118
| New | +$51.1K | ﹤0.01% | 6325 |
|
Other funds holding AUPH
TCM
NMC
